2-acetylthiomethyl-3-(4-methylbenzoyl)propionic acid,
esonarimod,
KE 298,
KE-298,
Esonarimod,
101973-77-7,
KE-298,
2-Acetylthiomethyl-3-(4-methylbenzoyl)propionic acid,
NCGC00182987-01,
2-(acetylsulfanylmethyl)-4-(4-methylphenyl)-4-oxobutanoic acid,
Benzenebutanoic acid, a-[(acetylthio)methyl]-4-methyl-g-oxo-;Benzenebutanoic acid, a-[(acetylthio)methyl]-4-methyl-g-oxo-,
Esonarimod [INN],
Esonarimod KE-298,
Esonarimod (JAN/INN),
Esonarimod (KE-298),
DSSTox_CID_28731,
DSSTox_RID_83000,
DSSTox_GSID_48805,
AC1L2T05,
SCHEMBL3044466,
CHEMBL2003782,
DTXSID9048805,
CHEBI:31559,
BCP29128,
Tox21_113282,
HY-19440,
CAS-101973-77-7,
CS-0015542,
D01102,
(+-)-3-Mercapto-2-(p-methylphenacyl)propionic acid acetate,
Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-,
Sonatimod,
UNII-PF4079THQO,
D0MY7X,
PF4079THQO,
C14H16O4S,
C14-H16-O4-S,
CID127998,
KE 298,
KE-749,
KE-758,
NE-298,
(R)-KE-298,
(S)-KE-298,